Trials / Withdrawn
WithdrawnNCT00713674
Comparison of Decolonization of Methicillin-resistant Staphylococcus Aureus (MRSA) Using Theraworx
Comparison of Decolonization of MRSA Using Theraworx
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Mercy Research · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.
Detailed description
Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Theraworx | Theraworx swab intranasal BID for 5 days |
| DRUG | mupirocin antibiotic ointment | mupirocin antibiotic ointment swab intranasal BID for 5 days |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-02-01
- Completion
- 2009-02-01
- First posted
- 2008-07-11
- Last updated
- 2017-03-23
Source: ClinicalTrials.gov record NCT00713674. Inclusion in this directory is not an endorsement.